Cargando…
Using a Transection Paradigm to Enhance the Repair Mechanisms of an Investigational Human Cell Therapy
One promising strategy in cell therapies for Parkinson’s disease (PD) is to harness a patient’s own cells to provide neuroprotection in areas of the brain affected by neurodegeneration. No treatment exists to replace cells in the brain. Thus, our goal has been to support sick neurons and slow neurod...
Autores principales: | Chau, Monica J., Quintero, Jorge E., Monje, Paula V., Voss, Stephen Randal, Welleford, Andrew S., Gerhardt, Greg A., van Horne, Craig G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523845/ https://www.ncbi.nlm.nih.gov/pubmed/36169034 http://dx.doi.org/10.1177/09636897221123515 |
Ejemplares similares
-
Transection injury differentially alters the proteome of the human sural nerve
por: Chau, Monica J., et al.
Publicado: (2022) -
RNA Sequencing of Human Peripheral Nerve in Response to Injury: Distinctive Analysis of the Nerve Repair Pathways
por: Welleford, Andrew S., et al.
Publicado: (2020) -
Gait and Balance Changes with Investigational Peripheral Nerve Cell Therapy during Deep Brain Stimulation in People with Parkinson’s Disease
por: Gera, Geetanjali, et al.
Publicado: (2021) -
Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design
por: Quintero, Jorge E, et al.
Publicado: (2022) -
Histological characteristics of ligament healing after bio-enhanced repair of the transected goat ACL
por: Nguyen, D Tan, et al.
Publicado: (2015)